Cyprus vs Ireland: Incidence of tuberculosis
Incidence of tuberculosis over time
- Cyprus
- Ireland
How they compare
Ireland currently reports 6.2 per 100,000 people against 5.5 per 100,000 people in Cyprus, a difference of 0.7 per 100,000 people.
That makes Ireland's figure about 1.1 times Cyprus's.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Ireland ahead.
Cyprus ranks 169th and Ireland ranks 166th of 208 countries.
Across the 3 decades both report, Cyprus averaged higher in 1 and Ireland in 2.
Head to head by decade
| Decade | Cyprus | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.25 per 100,000 people | 13.5 per 100,000 people | 7.25 per 100,000 people | Ireland |
| 2010s | 6.02 per 100,000 people | 8.58 per 100,000 people | 2.56 per 100,000 people | Ireland |
| 2020s | 5.82 per 100,000 people | 5.26 per 100,000 people | 0.56 per 100,000 people | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Cyprus or Ireland?
- Ireland, at 6.2 per 100,000 people against 5.5 per 100,000 people in Cyprus as of 2024.
- What is the difference in incidence of tuberculosis between Cyprus and Ireland?
- 0.7 per 100,000 people, with Ireland ahead.
- How many years of comparable data are there for Cyprus and Ireland?
- 25 years are reported by both, from 2000 to 2024.
- How do Cyprus and Ireland rank globally for incidence of tuberculosis?
- Cyprus ranks 169th and Ireland ranks 166th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.